Clin2
NCT06425380Possibly a fitRecruiting

Resistant potato starch for liver cirrhosis and confusion

Hepatic EncephalopathyCirrhosis

Part of Brain & nervous system, Digestive system, Hormones & metabolism clinical trials.

This study is testing whether a special type of starch (resistant potato starch) can help people with cirrhosis who have had episodes of confusion from liver problems. It may help by changing the bacteria in your gut, which could reduce the risk of future confusion episodes.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
11 people
Ages
18 years to 99 years
Study type
Interventional

Who can take part

  • You have been diagnosed with cirrhosis (scarring of the liver).
  • You have had at least one episode of confusion or drowsiness caused by liver problems (overt hepatic encephalopathy) in the past year.
  • You have not been in the hospital or taken antibiotics (except rifaximin) in the last 4 weeks.
  • You have not taken lactulose, a medicine for liver-related confusion, in the last 4 weeks.
  • You have not had more than one alcoholic drink per week or used any illicit drugs in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06538077Recruiting· Phase 4
BCAA vs. Rifaximin to Prevent Recurrent Hepatic Encephalopathy

This trial compares two treatments—BCAA supplements and rifaximin—to see which is better at preventing another episode of confusion or coma in people with cirrhosis who have already had one. If you qualify, you would receive one of these treatments for several months.

Chandigarh
NCT06464952Recruiting
Prebiotics for PTSD and cirrhosis

This trial tests if a prebiotic supplement can improve gut health and PTSD symptoms in people with cirrhosis and PTSD. It aims to see if changing the gut microbiome can help both conditions.

Richmond, Virginia
NCT04073290Recruiting· Phase 4
Rifaximin and lactulose to prevent confusion after TIPS

This trial studies whether taking rifaximin plus lactulose can prevent a brain problem called hepatic encephalopathy (confusion) after TIPS, a procedure to reduce pressure in the liver. It may help people who are having TIPS planned and are at risk of this complication.

Leuven
NCT07683936Recruiting· Early Phase 1
Fecal transplant for brain issues after liver procedure

This trial tests if transferring healthy bacteria into your gut (fecal microbiota transplant) can help people who still get confusion episodes (hepatic encephalopathy) even after a TIPS procedure and while on standard medications like lactulose and rifaximin.

Xi'an
NCT07528690Not yet recruiting· Phase 2
Microbiota transplant therapy for hepatic encephalopathy

This trial tests whether transplanting healthy gut bacteria can help prevent confusion and brain problems caused by liver disease. You would receive either the bacteria treatment or standard medications to see if it reduces these episodes.

West Haven, Connecticut
NCT07792915Not yet recruiting· Phase 2
Potato starch to clear resistant gut bacteria

This trial tests whether taking a special potato starch daily can help remove resistant bacteria from your gut. It may lower the chance of future infections.

Madison, Wisconsin

Hear when a new Hepatic Encephalopathy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.